Head and Neck Cancers
📧 Sign up to get email alerts when something new happens for Head and Neck Cancers.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study [Phase 2]
A Phase 2 randomized trial investigates the effects of COX-2 and EGFR suppression on molecular markers of angiogenesis and proliferation in …
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Surufatinib in Recurrent/Metastatic Head and Neck Adenocarcinomas [Phase 2]
Phase 2 clinical trial update for Surufatinib in recurrent/metastatic head and neck adenocarcinomas (salivary gland origin) with unknown sta…